[AMRX] QoQ Quarter Result on 30-Jun-2022 [#Q2]

Stock
[AMRX] Amneal Pharmaceuticals, Inc.
Announcement Date
08-Aug-2022
Financial Year
2022
Quarter
30-Jun-2022 [#Q2]
Profit Trend
QoQ- -1,770.09%
YoY- -931.32%
Quarter Report
AMRX's Result
AMRX's Financial Summary
View:
Show?
Quarter Result
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
Revenue 557,540 609,759 545,557 559,355 497,633 536,896 528,593 3.62%
PBT -9,426 -7,655 2,180 -232,731 -9,921 -16,319 -2,043 177.40%
Tax 668 -1,797 4,570 7,350 -3,461 4,140 4,049 -69.95%
NP -10,094 -5,858 -2,390 -120,808 -6,460 -6,377 -4,237 78.47%
Tax Rate - - -209.63% - - - - -
Total Cost 567,634 615,617 547,947 680,163 504,093 543,273 532,830 4.31%
Ratio Analysis
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
NP Margin -1.81 -0.96 -0.44 -21.60 -1.30 -1.19 -0.80 72.42%
Per Share
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
EPS -0.07 -0.04 -0.02 -0.80 -0.04 -0.04 -0.03 76.01%
EPS Diluted -0.07 -0.04 -0.02 -0.80 -0.04 -0.04 -0.03 76.01%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.